Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Advanced Enzyme Tech released the audio recording of its conference call held on May 12, 2026. The call discussed the audited financial results for the quarter and year ended March 31, 2026, and is available on the company's website.
May 12 2026 15:05:00
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Advanced Enzymes Technologies Ltd. announced its Q4 FY26 consolidated results via a press release, with revenue growing 22% YoY to Rs.203.4 crore and net profit increasing 69% to Rs.45.3 crore. Full year FY26 net profit also rose 30% YoY.
May 09 2026 15:05:00
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Cancellation of Dividend
Advanced Enzymes' Board deferred the interim dividend declaration. The company stated this decision aims to preserve capital to provide flexibility for evaluating strategic avenues and maximizing long-term shareholder value.
May 09 2026 14:05:00
Advanced Enzyme Technologies Ltd - 540025 - Corporate Action-Board approves Dividend
Advanced Enzymes recommended a final dividend of ₹1.35 per equity share for FY26. The board deferred the interim dividend to preserve capital for future strategic flexibility.
May 09 2026 13:05:00
Advanced Enzyme Technologies Ltd - 540025 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Advanced Enzyme Technologies will host a conference call on May 12, 2026, at 9:00 AM IST, for analysts and investors. The call will discuss the financial results for the quarter and year ended March 31, 2026.
May 05 2026 17:05:00
Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Ltd. Board will meet on May 09, 2026. The agenda includes approving annual and Q4 FY26 financial results, and considering both final FY26 and interim FY27 dividends.
May 02 2026 18:05:00
Advanced Enzyme Technologies Limited
Advanced Enzyme board will convene on May 9, 2026, to approve the audited yearly financial results for the period ended March 2026. The meeting will also consider the recommendation of both final and interim dividends.
May 02 2026 18:05:00
Read More